| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.4 | 0.004 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |